| __timestamp | Amneal Pharmaceuticals, Inc. | Catalyst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 4473654 |
| Thursday, January 1, 2015 | 109679000 | 8597010 |
| Friday, January 1, 2016 | 118757000 | 7910260 |
| Sunday, January 1, 2017 | 109046000 | 7304399 |
| Monday, January 1, 2018 | 230435000 | 15875961 |
| Tuesday, January 1, 2019 | 289598000 | 36881187 |
| Wednesday, January 1, 2020 | 326727000 | 44233754 |
| Friday, January 1, 2021 | 365504000 | 49628000 |
| Saturday, January 1, 2022 | 399700000 | 58183000 |
| Sunday, January 1, 2023 | 429675000 | 133710000 |
Data in motion
In the competitive landscape of pharmaceuticals, understanding operational costs is crucial. Over the past decade, Amneal Pharmaceuticals, Inc. and Catalyst Pharmaceuticals, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. Amneal's SG&A expenses have surged by over 400% from 2014 to 2023, reflecting its aggressive expansion and market penetration strategies. In contrast, Catalyst Pharmaceuticals, Inc. has seen a more modest increase of approximately 290% in the same period, indicating a more conservative growth approach. Notably, in 2023, Catalyst's SG&A expenses spiked, reaching nearly 31% of Amneal's, a significant leap from just 5% in 2014. This divergence highlights the varied strategic priorities and operational efficiencies of these two industry players. As the pharmaceutical sector continues to evolve, monitoring such financial metrics will be key to understanding future market dynamics.
AstraZeneca PLC vs Catalyst Pharmaceuticals, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Amneal Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: BeiGene, Ltd. vs Amneal Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Viatris Inc. and Catalyst Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Intra-Cellular Therapies, Inc. vs Amneal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Bio-Techne Corporation vs Amneal Pharmaceuticals, Inc. Trends and Insights
Amneal Pharmaceuticals, Inc. and HUTCHMED (China) Limited: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Amicus Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Catalyst Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Catalyst Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Evotec SE Trends and Insights